• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Combination immunotherapy improved overall survival in patients with metastatic melanoma

  • in Oncology
  • — 15 Sep, 2013
Stephen Hodi
Stephen Hodi

CHICAGO— Overall survival improved by more than two-thirds in patients with metastatic melanoma randomised to have GM-CSF added to their ipilimumab therapy. A phase II study in 245 previously treated patients — comparing the effect of ipilumumab with or without the growth factor — also found side effects were lower among those receiving the combination. At the American Society of Clinical Oncology’s 2013 meeting in Chicago, Sarah Maxwell heard from Dr. Stephen Hodi, Assistant Professor of Medicine at the Dana-Farber Cancer Institute/Harvard Cancer Center, Boston and Dr. Lynn Schuchter Chief of Hematolgy/Oncology at the Abramson Cancer Center, University of Pennsylvania, Philadelphia.

You may also like...

  • Gender Disparity in Head and Neck Cancer Treatment and Outcomes Gender Disparity in Head and Neck Cancer Treatment and Outcomes 9 Jun, 2018
  • Dana Tsui Blood test for free tumour DNA could guide breast cancer therapy 3 Apr, 2013
  • Lung Cancer Radiation Therapy Increases Heart Disease Mortality Lung Cancer Radiation Therapy Increases Heart Disease Mortality 24 Aug, 2016

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Normal stem cells are not depleted in acute myeloid leukaemia and could be targeted therapeutically
  • Next story PD 1 inhibitor nivolumab shows promising activity in metastatic melanoma
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • Microbiome Diversity Key To Survival After…
    • Childhood Obesity—Whose Business Is It?
    • Which New Combination for Metastatic Renal Cell Cancer?
    • Genomic-led AML Clinical Decision Making Within Seven Days
  • Home
  • Oncology
  • Combination immunotherapy improved overall survival in patients with metastatic melanoma

© COPYRIGHT 2020 AUDIOMEDICA.COM.